Oncology
Oncology
Advertisement
Rob DillardGynecologic Cancer | October 3, 2024
A study identified possible prognostic factors and survival patterns based on histology type in endometrial cancer patients.
Read More
Rob DillardBreast Cancer | October 3, 2024
Two UCF researchers were bestowed state grants to support their innovative projects to fight breast cancer.
Dr. Sadie Dobrozsi, EvolentBreast Cancer | October 2, 2024
Dr. Sadie Dobrozsi spoke on the importance of genetic testing in breast cancer to better understand the disease.
Rob DillardHead and Neck Cancer | September 27, 2024
Oral bacteria are a risk factor for head and neck squamous cell cancer.
Rob DillardBreast Cancer | September 26, 2024
Cancer incidence trends in 2021 mostly returned to their pre-COVID-19 pandemic levels, with the exception of breast cancer.
Rob DillardBreast Cancer | September 26, 2024
A study analyzed the correlation between cancer-related cognitive impairment and neurotransmission pathways.
Rob DillardBreast Cancer | September 19, 2024
A new study finds that 3D digital breast tomosynthesis is more effective at detecting BC than traditional 2D.
Rob DillardHead and Neck Cancer | September 20, 2024
A novel predictive digital pathology biomarker demonstrates high predictive response in HNC.
Rob DillardSkin Cancer | September 20, 2024
The combination therapy of sotiga with pembrolizumab is effective at treating patients with metastatic melanoma.
Rob DillardSOHO 2024: Focus on CLL | September 12, 2024
Cytogenic anomaly screening should be performed in every patient with CLL.
Rob DillardSOHO 2024: Focus on CLL | September 12, 2024
A study finds that CD200 is an effective diagnostic marker in atypical chronic lymphocytic leukemia.
Rob DillardSOHO 2024: Focus on CLL | September 12, 2024
For patients with B-cell CLL, a simple method is effective at identifying patients eligible for personalized therapies.
Rob DillardOncology | September 12, 2024
Oral target inhibitors are a viable treatment option for CLL patients with serve renal dysfunction.
Jordana JampelColorectal Cancer | September 11, 2024
1L zanidatamab plus chemo with or without bevacizumab demonstrated antitumor activity and manageable safety in mCRC.
Rob DillardSkin Cancer | September 11, 2024
A new study shows a notable decline in both melanoma incidence and mortality among young people in Sweden.
Rob DillardBreast Cancer | September 10, 2024
Two international studies show that women who breastfeed following BC treatment do not have an increased risk of BC.
Jordana JampelPancreatic Cancer | September 6, 2024
The use of EUS and multimodal AI across all levels of endoscopic expertise proved beneficial.
Rob DillardBreast Cancer | September 5, 2024
New research suggests ICI therapy improves efficacy outcomes in early-stage breast cancer over adjuvant therapy.
Rob DillardBreast Cancer | September 5, 2024
Researchers identified immune system white blood cells that appear closely related to BC cells that are likely to spread.
Dr. Andrew HertlerGynecologic Cancer | September 4, 2024
Dr. Andrew Hertler explains why health disparities exist for Black women with ovarian cancer.
Advertisement
Advertisement
Advertisement
Latest News

October 3, 2024